CTMS & CDM platform enabling efficient trial planning, execution, compliance, and faster decision-making
Total Trials
13
As Lead Sponsor
0
As Collaborator
Total Enrollment
1,015,619
NCT02521649
Dose-ranging Study to Evaluate Antibody Response to G17DT in Patients With Gastric Cancer
Phase: Phase 2
Role: Collaborator
Start: Sep 30, 1998
Completion: Jan 31, 2001
NCT00559052
An Open-Label Study to Evaluate the Intraduodenal Delivery of Enzymes From Administration of VIOKASE16 in Exocrine Pancreatic Insufficiency (EPI)
Start: Mar 31, 2008
Completion: Feb 28, 2009
NCT02493491
Neurogenic Dysphonia/Dysphagia Registry
Phase: N/A
Start: Jun 30, 2015
Completion: Sep 30, 2016
NCT02374450
A Surveillance Study of Diseases Specified as Adverse Events of Special Interest, of Other Adverse Events Leading to Hospitalisation or Death, and of Meningitis in Children in Africa Prior to Implementation of the RTS,S/AS01E Candidate Vaccine
Start: Oct 5, 2015
Completion: Aug 2, 2022
NCT03077048
Short-term Metabolic Effects of Ketosteril® Supplemented Low Protein Diet in Pre-dialysis Chronic Kidney Disease (CKD) Patients
Phase: Phase 1/2
Start: Mar 30, 2017
Completion: May 2, 2018
NCT03174444
Small Media Interventions to Increase Colorectal Cancer Screening Among Chinese Americans
Start: Aug 15, 2017
Completion: Sep 30, 2019
NCT03348514
Safety, Dose Tolerance, Pharmacokinetics, and Pharmacodynamics Study of CPX-POM in Patients With Advanced Solid Tumors
Phase: Phase 1
Start: Jan 15, 2018
Completion: May 31, 2020
NCT03947580
Clinical Trial of Dvectis Pads in Comparison to no Pad Use in Patients With Chronic Lumbar Spine Pain
Start: Apr 9, 2018
Completion: Dec 15, 2018
NCT03655990
A Full-Arch Implant- Supported Prosthesis in the Upper and/or Lower Jaw-USA
Start: Aug 7, 2018
Completion: May 3, 2022
NCT04441099
NBE-002 in Patients With Advanced Solid Tumors
Start: Jun 19, 2020
Completion: Aug 14, 2023
NCT04508179
A Phase 1 SAD and MAD Study of the Safety, Tolerability and PK of 7HP349 in Normal Healthy Male Subjects
Start: Oct 28, 2020
Completion: Oct 25, 2021
NCT04838795
Sisonke (Together): OPEN LABEL TRIAL COVID-19
Phase: Phase 3
Start: Feb 17, 2021
Completion: Mar 31, 2022
NCT05148845
Sisonke 2 - A COVID-19 Vaccine Boost Open Label Study.
Start: Nov 10, 2021
Completion: Jun 30, 2023
Loading map...